[{"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-001", "question": "A 14-year-old boy with juvenile idiopathic arthritis presents with acute onset of fever, rash, and joint swelling after starting etanercept therapy. Laboratory findings include elevated ferritin, pancytopenia, and hypertriglyceridemia. What is the most appropriate next step in management?", "options": ["Discontinue etanercept and initiate high-dose corticosteroids", "Administer intravenous immunoglobulin", "Start rituximab infusion", "Perform bone marrow biopsy immediately", "Initiate broad-spectrum antibiotics"], "answer": "A", "answer_index": 0, "explanation": "This presentation is consistent with macrophage activation syndrome (MAS), a life-threatening complication in rheumatic diseases like juvenile idiopathic arthritis, often triggered by biologic agents such as etanercept. Discontinuing the offending agent and starting high-dose corticosteroids is the initial management to control the cytokine storm. Bone marrow biopsy may confirm hemophagocytosis but is not the immediate next step, and antibiotics are inappropriate without evidence of infection.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "I need to identify the condition and appropriate management for this 14-year-old boy with juvenile idiopathic arthritis who developed concerning symptoms after starting etanercept.\n\nThe clinical presentation includes:\n- Acute onset fever, rash, and joint swelling after etanercept (TNF inhibitor) initiation\n- Elevated ferritin\n- Pancytopenia\n- Hypertriglyceridemia\n\nThese findings are consistent with macrophage activation syndrome (MAS), also known as hemophagocytic lymphohistiocytosis (HLH), which is a potentially life-threatening complication of rheumatic diseases, particularly juvenile idiopathic arthritis. It can be triggered by medications, including biologics like etanercept.\n\nFor management of MAS:\n- The offending agent should be discontinued immediately\n- High-dose corticosteroids are the first-line treatment to rapidly suppress the hyperinflammatory state\n- Other options may be considered but aren't the first step\n\nThe answer is (A)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-002", "question": "A 65-year-old man with hypertrophic cardiomyopathy develops sudden syncope during exercise. Echocardiography shows left ventricular outflow tract obstruction with a gradient of 80 mmHg. Despite beta-blocker therapy, symptoms persist. What is the most definitive management option?", "options": ["Surgical septal myectomy", "Alcohol septal ablation", "Implantable cardioverter-defibrillator placement", "Dual-chamber pacing", "Verapamil initiation"], "answer": "A", "answer_index": 0, "explanation": "Surgical septal myectomy is the gold standard for symptomatic hypertrophic cardiomyopathy with severe outflow tract obstruction refractory to medical therapy, offering superior long-term outcomes in experienced centers. Alcohol septal ablation is an alternative but carries risks like heart block and is less effective in younger patients. ICD placement addresses arrhythmic risk but not the obstruction itself.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "To answer this question, I need to consider the management options for symptomatic hypertrophic cardiomyopathy (HCM) with significant left ventricular outflow tract (LVOT) obstruction that is refractory to medical therapy.\n\nThe patient has:\n- Symptomatic HCM with syncope during exercise\n- Significant LVOT obstruction (gradient 80 mmHg)\n- Persistent symptoms despite beta-blocker therapy\n\nFor patients with HCM and significant LVOT obstruction who remain symptomatic despite optimal medical therapy, septal reduction therapy is indicated. The two main septal reduction options are surgical septal myectomy and alcohol septal ablation.\n\nSurgical septal myectomy is considered the gold standard and most definitive treatment for drug-refractory, symptomatic LVOT obstruction in HCM. It has excellent long-term outcomes with low mortality at experienced centers.\n\nAlcohol septal ablation is an alternative for patients who are high-risk surgical candidates, but has higher rates of complications including heart block and less predictable results.\n\nAn ICD is indicated for secondary prevention after cardiac arrest or for primary prevention in high-risk patients, but doesn't address the LVOT obstruction.\n\nDual-chamber pacing has limited efficacy for reducing LVOT gradients and is generally considered a third-line option.\n\nVerapamil can be used as medical therapy but would not be more effective than the beta-blocker that has already failed.\n\nThe answer is (A)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-003", "question": "A term neonate develops respiratory distress and hypotension shortly after birth. Physical exam reveals hepatomegaly and poor perfusion. Echocardiogram shows dilated cardiomyopathy. Maternal history includes untreated systemic lupus erythematosus. What is the underlying mechanism?", "options": ["Transplacental passage of anti-Ro/SSA antibodies causing atrioventricular block", "Congenital viral infection leading to myocarditis", "Inborn error of metabolism affecting cardiac function", "Asphyxia-induced hypoxic cardiomyopathy", "Genetic mutation in sarcomeric proteins"], "answer": "A", "answer_index": 0, "explanation": "Neonatal lupus from maternal anti-Ro/SSA antibodies can cause complete heart block and cardiomyopathy, leading to heart failure in the newborn. This is distinct from viral myocarditis, which typically presents later and lacks the maternal autoimmune history. Metabolic or genetic causes are less likely without additional syndromic features.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "To answer this question, I need to analyze the clinical presentation and maternal history.\n\nKey findings:\n- Term neonate with respiratory distress and hypotension\n- Hepatomegaly and poor perfusion\n- Dilated cardiomyopathy on echocardiogram\n- Mother has untreated systemic lupus erythematosus (SLE)\n\nThe maternal history of untreated SLE is particularly significant. SLE is associated with autoantibodies, including anti-Ro/SSA antibodies, which can cross the placenta and affect the fetus.\n\nWhile anti-Ro/SSA antibodies are classically associated with congenital heart block (option A), they can also cause a more diffuse myocardial inflammation leading to dilated cardiomyopathy in neonates born to mothers with SLE.\n\nCongenital viral infection (option B) could cause myocarditis, but there's no mention of maternal viral infection.\n\nInborn errors of metabolism (option C) can present with cardiomyopathy, but the maternal SLE provides a more direct explanation.\n\nAsphyxia-induced hypoxic cardiomyopathy (option D) would typically have a history of perinatal asphyxia.\n\nGenetic mutations in sarcomeric proteins (option E) can cause cardiomyopathy but wouldn't be related to maternal SLE.\n\nThe answer is (A)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-004", "question": "A 28-year-old woman at 32 weeks gestation presents with severe preeclampsia and acute dyspnea. Echocardiography reveals peripartum cardiomyopathy with ejection fraction of 30%. What is the most critical intervention to improve maternal outcomes?", "options": ["Immediate delivery via cesarean section", "Initiate bromocriptine to suppress prolactin", "Administer intravenous furosemide and vasodilators", "Start anticoagulation with low-molecular-weight heparin", "Perform urgent cardiac transplantation evaluation"], "answer": "B", "answer_index": 1, "explanation": "Bromocriptine inhibits prolactin, which is implicated in the pathogenesis of peripartum cardiomyopathy, and has shown benefit in improving left ventricular function when added to standard heart failure therapy. Immediate delivery may be necessary for preeclampsia but does not directly address cardiomyopathy. Diuretics and vasodilators manage symptoms but are not disease-modifying in this context.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "To address this case of severe preeclampsia with peripartum cardiomyopathy at 32 weeks gestation, I need to consider the most critical intervention for improving maternal outcomes.\n\nThe patient has:\n- Severe preeclampsia\n- Acute dyspnea\n- Peripartum cardiomyopathy with EF of 30%\n- 32 weeks gestation\n\nIn peripartum cardiomyopathy with severe preeclampsia, the definitive treatment that most improves maternal outcomes is delivery of the fetus, as this removes the ongoing physiologic stress on the maternal cardiovascular system and allows for more aggressive treatment of heart failure. The severe preeclampsia itself is also an indication for delivery.\n\nWhile medical management (option C), anticoagulation (option D), bromocriptine (option B), and transplant evaluation (option E) may all have roles in the comprehensive management of peripartum cardiomyopathy, the most critical intervention to improve maternal outcomes in this scenario is delivery.\n\nThe answer is (A)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-005", "question": "In the ICU, a 55-year-old patient with septic shock on vasopressors develops acute kidney injury and metabolic acidosis. Despite fluid resuscitation, oliguria persists. Continuous renal replacement therapy is initiated. What is the most appropriate modality to optimize hemodynamic stability?", "options": ["Continuous venovenous hemodiafiltration with citrate anticoagulation", "Intermittent hemodialysis with bicarbonate buffer", "Sustained low-efficiency dialysis", "Peritoneal dialysis", "Continuous venovenous hemofiltration alone"], "answer": "A", "answer_index": 0, "explanation": "Continuous venovenous hemodiafiltration (CVVHDF) provides both convective and diffusive clearance, making it ideal for septic shock with acidosis, and citrate anticoagulation minimizes clotting while providing regional effects. Intermittent hemodialysis can cause hemodynamic instability in critically ill patients. Peritoneal dialysis is less efficient for rapid toxin removal in this setting.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "For a patient with septic shock on vasopressors who has developed acute kidney injury and metabolic acidosis, hemodynamic stability is a critical concern when selecting a renal replacement therapy modality.\n\nContinuous venovenous hemodiafiltration (CVVHDF) with citrate anticoagulation offers several advantages for hemodynamically unstable patients:\n\n1. The continuous nature of the therapy allows for gradual fluid removal and solute clearance, minimizing rapid fluid shifts that could worsen hypotension in a vasopressor-dependent patient.\n\n2. Citrate anticoagulation provides regional anticoagulation within the circuit without systemic anticoagulation, which is beneficial in critically ill patients who may have coagulation abnormalities.\n\n3. CVVHDF combines diffusion and convection principles, allowing for efficient clearance of both small and middle-sized molecules, which is important for managing metabolic acidosis.\n\nIntermittent hemodialysis and sustained low-efficiency dialysis can cause more hemodynamic instability due to more rapid fluid shifts. Peritoneal dialysis is rarely used in acute settings in the ICU, especially for patients with septic shock. Continuous venovenous hemofiltration alone may not provide optimal clearance of small solutes compared to CVVHDF.\n\nThe answer is (A)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-006", "question": "A 45-year-old woman with rheumatoid arthritis on methotrexate develops progressive dyspnea and dry cough. High-resolution CT shows subpleural reticular opacities and traction bronchiectasis. Pulmonary function tests reveal restrictive pattern. What is the most likely diagnosis?", "options": ["Methotrexate-induced interstitial lung disease", "Rheumatoid arthritis-associated usual interstitial pneumonia", "Hypersensitivity pneumonitis from environmental exposure", "Non-specific interstitial pneumonia", "Cryptogenic organizing pneumonia"], "answer": "B", "answer_index": 1, "explanation": "Rheumatoid arthritis can cause interstitial lung disease with a usual interstitial pneumonia pattern, which is more common than methotrexate toxicity in long-term users. Methotrexate-induced ILD typically presents acutely and improves upon discontinuation, unlike this progressive course. Hypersensitivity pneumonitis would show upper lobe predominance and different triggers.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "To determine the most likely diagnosis, I'll analyze the key clinical features:\n\nPatient profile:\n- 45-year-old woman with rheumatoid arthritis\n- On methotrexate therapy\n- Progressive dyspnea and dry cough\n\nImaging findings:\n- HRCT shows subpleural reticular opacities\n- Traction bronchiectasis\n\nPFT results:\n- Restrictive pattern\n\nAnalysis of options:\nA. Methotrexate-induced ILD: Methotrexate is a known cause of drug-induced lung toxicity. The presentation with progressive dyspnea and dry cough in a patient on this medication is highly suspicious.\n\nB. RA-associated UIP: While RA can cause ILD (particularly UIP pattern), the temporal relationship with methotrexate therapy makes drug toxicity more likely as the primary cause.\n\nC. Hypersensitivity pneumonitis: No history of environmental exposure is mentioned, and the HRCT findings are more consistent with drug-induced ILD.\n\nD. NSIP: While NSIP can occur in RA, the clinical context strongly suggests medication-induced lung disease.\n\nE. COP: The HRCT findings of subpleural reticular opacities with traction bronchiectasis are not typical for COP, which usually shows patchy consolidation.\n\nGiven the clinical context of a patient on methotrexate with progressive respiratory symptoms and compatible imaging findings, methotrexate-induced ILD is most likely.\n\nThe answer is (A)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-007", "question": "A 2-year-old child with hypoplastic left heart syndrome post-Norwood procedure presents with cyanosis and metabolic acidosis. Echocardiography shows right ventricular dysfunction and tricuspid regurgitation. What is the most appropriate pharmacologic intervention?", "options": ["Milrinone infusion for inotropic support", "Prostaglandin E1 to maintain ductal patency", "Sildenafil for pulmonary hypertension", "Digoxin for rate control", "Epinephrine bolus for hypotension"], "answer": "A", "answer_index": 0, "explanation": "Milrinone provides inotropic support and pulmonary vasodilation, crucial for right ventricular failure in single-ventricle physiology after Norwood. Prostaglandin E1 is used preoperatively but not post-Norwood. Sildenafil targets pulmonary hypertension but lacks the inotropic effect needed here.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "To address this clinical scenario, I need to consider the patient's condition and the most appropriate pharmacologic intervention.\n\nThis is a 2-year-old with hypoplastic left heart syndrome (HLHS) who has already had a Norwood procedure (first stage of palliation). The patient presents with cyanosis and metabolic acidosis, indicating poor tissue perfusion. Echocardiography shows right ventricular dysfunction and tricuspid regurgitation.\n\nIn HLHS post-Norwood, the right ventricle is the systemic ventricle, so right ventricular dysfunction is particularly concerning as it affects systemic circulation. The combination of RV dysfunction and tricuspid regurgitation suggests the need for improved cardiac contractility.\n\nLet me evaluate each option:\n\nA. Milrinone - A phosphodiesterase inhibitor that provides both inotropic support (increases contractility) and vasodilation. It would improve right ventricular function and reduce afterload.\n\nB. Prostaglandin E1 - Used to maintain ductal patency, primarily in neonates before surgical palliation. Not typically used in a 2-year-old post-Norwood.\n\nC. Sildenafil - Used for pulmonary hypertension, but there's no indication of pulmonary hypertension in this scenario.\n\nD. Digoxin - Used for rate control and mild inotropic effect, but not first-line for acute decompensation with metabolic acidosis.\n\nE. Epinephrine bolus - Used for hypotension or cardiac arrest, but there's no mention of hypotension, and a continuous inotrope would be more appropriate than bolus therapy.\n\nGiven the right ventricular dysfunction in a patient with HLHS post-Norwood, milrinone would be most appropriate as it provides inotropic support while also reducing afterload through vasodilation.\n\nThe answer is (A)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-008", "question": "A 70-year-old man with atrial fibrillation on anticoagulation develops acute chest pain and hypotension. Coronary angiography shows no obstructive disease, but left ventriculography reveals apical ballooning. What is the underlying pathophysiology?", "options": ["Catecholamine surge leading to transient myocardial stunning", "Spontaneous coronary artery dissection", "Myocarditis from viral infection", "Embolic occlusion of distal coronaries", "Vasospasm induced by ergonovine"], "answer": "A", "answer_index": 0, "explanation": "Takotsubo cardiomyopathy involves catecholamine-mediated myocardial stunning, mimicking acute coronary syndrome without angiographic abnormalities. Dissection would show vessel irregularities on angiography. Myocarditis typically presents with inflammatory markers and different ventricular patterns.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "The clinical presentation describes Takotsubo cardiomyopathy (stress-induced cardiomyopathy), characterized by:\n- Acute chest pain and hypotension\n- No obstructive coronary disease on angiography\n- Apical ballooning on ventriculography\n- Occurs in an elderly patient with a stressful condition\n\nTakotsubo cardiomyopathy is primarily caused by a surge in catecholamines (epinephrine, norepinephrine) that occurs during physical or emotional stress. This catecholamine excess leads to transient myocardial stunning, particularly affecting the apex of the left ventricle, creating the characteristic \"apical ballooning\" appearance.\n\nThe other options don't fit this classic presentation:\n- Spontaneous coronary dissection typically affects younger women\n- Myocarditis would show different findings on imaging\n- Embolic occlusion would show visible occlusions on angiography\n- Vasospasm would typically respond to vasodilators and wouldn't cause the apical ballooning pattern\n\nThe answer is (A)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-009", "question": "A 35-year-old pregnant woman at 28 weeks with antiphospholipid syndrome develops thrombocytopenia and elevated liver enzymes. Fetal monitoring shows growth restriction. What is the most appropriate management strategy?", "options": ["Low-dose aspirin and low-molecular-weight heparin continuation with close monitoring", "Immediate delivery to prevent maternal deterioration", "Plasmapheresis for antibody removal", "Intravenous immunoglobulin infusion", "Switch to unfractionated heparin"], "answer": "A", "answer_index": 0, "explanation": "In antiphospholipid syndrome during pregnancy, continuing low-dose aspirin and LMWH is standard to manage thrombotic risks and prevent complications like HELLP-like syndrome, with vigilant monitoring. Immediate delivery is premature at 28 weeks without severe features. IVIG is not first-line and reserved for refractory cases.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "This case describes a 35-year-old pregnant woman at 28 weeks with antiphospholipid syndrome who has developed thrombocytopenia, elevated liver enzymes, and fetal growth restriction. These findings suggest possible HELLP syndrome (Hemolysis, Elevated Liver enzymes, Low Platelets) or preeclampsia superimposed on her antiphospholipid syndrome.\n\nAt 28 weeks, the fetus is still premature, but the combination of maternal deterioration with laboratory abnormalities and fetal growth restriction indicates a serious situation that requires intervention.\n\nOption A (continuing current therapy with monitoring) would be insufficient given the active deterioration.\nOption B (immediate delivery) is appropriate when maternal condition is deteriorating with signs of end-organ damage.\nOption C (plasmapheresis) is not first-line for this presentation.\nOption D (IVIG) is not indicated as first-line therapy for this condition.\nOption E (switching to unfractionated heparin) would not address the underlying problem.\n\nGiven the maternal deterioration with thrombocytopenia, elevated liver enzymes, and fetal growth restriction, delivery is indicated to prevent further maternal complications.\n\nThe answer is (B)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-010", "question": "In the critical care unit, a 60-year-old patient with acute respiratory distress syndrome on mechanical ventilation develops refractory hypoxemia despite prone positioning. Extracorporeal membrane oxygenation is considered. What is the primary indication for venovenous ECMO in this scenario?", "options": ["PaO2/FiO2 ratio less than 80 with FiO2 greater than 90%", "Hypercapnia unresponsive to increased minute ventilation", "Right ventricular failure on echocardiography", "Sepsis-induced myocardial depression", "Barotrauma from high plateau pressures"], "answer": "A", "answer_index": 0, "explanation": "Venovenous ECMO is indicated for severe ARDS when PaO2/FiO2 <80 on FiO2 >90%, despite optimal ventilatory support, to provide gas exchange. Hypercapnia alone may be managed with permissive strategies or ECCO2R. Right ventricular failure would prompt venoarterial ECMO consideration instead.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "To determine the primary indication for venovenous ECMO in this scenario, I need to consider the patient's condition and the specific indications for VV-ECMO versus VA-ECMO.\n\nThe patient has:\n- Acute respiratory distress syndrome (ARDS)\n- Refractory hypoxemia despite prone positioning\n- Is being considered for ECMO\n\nVenovenous (VV) ECMO is specifically used for respiratory support when conventional mechanical ventilation is failing. The primary indications include:\n\nA. PaO2/FiO2 ratio less than 80 with FiO2 greater than 90% - This represents severe hypoxemia despite maximal oxygen therapy, which is a classic indication for VV-ECMO in ARDS.\n\nB. Hypercapnia unresponsive to increased minute ventilation - While this can be an indication, it's not the primary one in this scenario of refractory hypoxemia.\n\nC. Right ventricular failure - This would typically be an indication for venoarterial (VA) ECMO, not VV-ECMO.\n\nD. Sepsis-induced myocardial depression - This is primarily a cardiac issue requiring VA-ECMO.\n\nE. Barotrauma from high plateau pressures - While ECMO can allow for lung-protective ventilation, this alone is not typically the primary indication.\n\nGiven the scenario of refractory hypoxemia in ARDS, the most appropriate indication is severe hypoxemia as measured by a very low PaO2/FiO2 ratio despite maximal conventional therapy.\n\nThe answer is (A)"}]